Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Joel M. Kupfer"'
Autor:
Adhir Shroff, Joel M. Kupfer, Sunil V. Rao, Ronald P. Caputo, Ian C. Gilchrist, Bernadette Speiser, Olivier F. Bertrand, Samir Pancholy
Publikováno v:
JAMA cardiology. 1(2)
Importance The evolution of percutaneous coronary intervention (PCI) has led to improved safety and efficacy, such that overnight observation can be avoided in some patients. We sought to provide a narrative review of the current literature regarding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df86675b6bba940f803809e9da3be3b6
https://pubmed.ncbi.nlm.nih.gov/27437896
https://pubmed.ncbi.nlm.nih.gov/27437896
Autor:
Herbert D. Aronow, Srihari S. Naidu, Daniel M. Kolansky, Faisal Latif, Joel M. Kupfer, Sunil V. Rao, Suresh Mulukutla, Rajesh V. Swaminathan, Lyndon C. Box, James C. Blankenship, Peter L. Duffy
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 88(3)
The SCAI Expert Consensus Statement: 2012 Best Practices in the Cardiac Catheterization Laboratory provides standards for preprocedure, intraprocedure, and postprocedure evaluation and management, and served as a patient-centered approach to safety a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff2c31fad73f7ef46f3da47c4b6378d3
https://pubmed.ncbi.nlm.nih.gov/27137680
https://pubmed.ncbi.nlm.nih.gov/27137680
Autor:
Joel M. Kupfer
Publikováno v:
JAMA. 315(4)
When should a physician retire? This question is being asked more frequently as the number of physicians in the United States older than 60 years continues to increase. In 2012, it was estimated that 26% or nearly 241 000 of all actively licensed phy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::012171f5c2bca249be2cf5cb301b3a5a
https://pubmed.ncbi.nlm.nih.gov/26720141
https://pubmed.ncbi.nlm.nih.gov/26720141
Autor:
Xin Ming Ruan, Jack M. Matloff, James S. Forrester, Guoging Liu, Joel M. Kupfer, Aurilo Chaux
Publikováno v:
Human Gene Therapy. 5:1437-1443
Within the first year, 15-20% of coronary artery saphenous bypass vein grafts (SVGs) occlude because of thrombosis or progressive intimal hyperplasia. One potential new strategy to reduce this complication would be to introduce antithrombotic or anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45d2a21b3103baa4a5982669a4a65685
https://doi.org/10.1089/hum.1994.5.12-1437
https://doi.org/10.1089/hum.1994.5.12-1437
Autor:
Stanley A. Rubin, Joel M. Kupfer
Publikováno v:
Journal of Molecular and Cellular Cardiology. 24:631-639
Recent data suggest that the heart can act as both a source and target for the actions of polypeptide growth factors. Insulin-like growth factor I (IGF-I) is a polypeptide that has both mitogenic and differentiation properties that function at the au
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dbab89ac2fc8c3df1f84bef6575cf90
https://doi.org/10.1016/0022-2828(92)91047-9
https://doi.org/10.1016/0022-2828(92)91047-9
Autor:
Paul Kligfield, Joel M. Kupfer
Publikováno v:
The American Journal of Cardiology. 67:981-986
Although variation in ventricular cycle length during Wenckebach-type second-degree atrioventricular block traditionally has been explained by the direction of incremental change in PR lengthening preceding the blocked complex, changing PP intervals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74897a5b6b1b882f0da30441a930f53a
https://doi.org/10.1016/0002-9149(91)90171-g
https://doi.org/10.1016/0002-9149(91)90171-g
Autor:
Paul Kligfield, Joel M. Kupfer
Publikováno v:
The American Journal of Cardiology. 68:835-836
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46aeda1ea8508a784547d59a645628ad
https://doi.org/10.1016/0002-9149(91)90687-g
https://doi.org/10.1016/0002-9149(91)90687-g